EU OKs Eli Lilly’s $5.4B bid for Novartis division

Published



BRUSSELS (AP) — The European Union’s antitrust authority says it has approved the $5.4 billion sale of Novartis’ animal health division to U.S. pharmaceutical firm Eli Lilly.

The 28-nation bloc’s executive Commission said Friday the sale won’t hinder competition because the merged firm will continue to face a number of strong competitors.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.